Antibody Therapeutics for Life

Notices

Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine is invited to give a keynote presentation at 9TH CLINICAL TRIALS INNOVATION PROGRAMME on April 26-27, 2018.
  • Written by Admin
  • Written date 2019-01-14 11:33:25
  • Inquire 4459

PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine 

is invited to give a keynote presentation at 9TH CLINICAL TRIALS INNOVATION PROGRAMME on April 26-27, 2018.

https://worldbi.co.uk/CTIPEU/speakers.php

 

 

Event: 9TH CLINICAL TRIALS INNOVATION PROGRAMME

Presentation Date: Thursday, April 26th, 2018

Presentation Time: 12:10 - 12:40 PM

Location: Frankfurt, GERMANY

 

 

For investors attending the 9TH CLINICAL TRIALS INNOVATION PROGRAMME, please contact PharmAbcine Investor Relations and business development 

to schedule a meeting with management at sungwoo.kim@pharmabcine.com.

List





Prev Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine is invited to g...
Next ``Preclinical pharmacokinetics, interspecies scaling, and pharmacokinetics of a ...